People · Operator
Named in public records as an officer, director or promoter · active 2016–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| UVision 360, Inc. | — | Biotechnology | Seed | $4.6M | $155.7M | 2016 |
| Plakous Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $175K | $9.7M | 2019 |
Allison London Brown at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Allison London Brown on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Carr | 1 | 5 |
| Jack Snoke | 1 | 2 |
| Ray Krauss | 1 | 2 |
| Peter A. Johnson | 1 | 1 |
| Scott A. Washburn | 1 | 1 |
| Seth A. Tomblyn | 1 | 1 |
| Pamela Levy | 1 | 1 |
| Robert W. Boyce | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.